Physician profile
Lyle T Modlin
NPI 1851307045
$1,641.42
in general payments reported to CMS, 2019-2025
23 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $20.80 · 2021: $31.54 · 2022: $277 · 2023: $267 · 2024: $492 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $192.57 | 2022-2024 | Senza |
| Bioventus LLC | $140.68 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $131.95 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Abbott Laboratories | $131.86 | 2024-2025 | Esprit, Proclaim |
| Convatec INC. | $124.99 | 2024 | |
| Melinta Therapeutics, LLC | $124.97 | 2019 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Treace Medical Concepts, INC. | $105.68 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $82.04 | 2022-2024 | Jublia |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Next Science LLC | $58.57 | 2023-2024 | Xperience, Blastx, Surgx |
| Stryker Corporation | $48.21 | 2023 | Ortholoc 2 Lapifuse, Ortholoc 3di |
| Paratek Pharmaceuticals, INC. | $46.92 | 2024-2025 | Nuzyra |
| Averitas Pharma INC. | $41.49 | 2025 | Qutenza |
| Boston Scientific Corporation | $35.16 | 2024 | Wavewriter Alpha Prime 16 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $33.34 | 2024 | Acumed, Osteomed |
| Heron Therapeutics, INC. | $31.54 | 2021 | |
| Silk Road Medical, INC. | $25.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Horizon Therapeutics Plc | $20.41 | 2023 | Krystexxa |
| Mimedx Group, INC. | $20.14 | 2024 | |
| Sebela Pharmaceuticals INC. | $19.19 | 2023 | Naftin |
| Medtronic, INC. | $18.60 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $17.96 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyle Modlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.